bluebird bio | LinkedIn (original) (raw)
``
Biotechnology Research
Somerville, Massachusetts 138,167 followers
Pursuing curative gene therapies to give patients and their families more bluebird days.
About us
bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days. With a dedicated focus on severe genetic diseases, bluebird has industry-leading programs for sickle cell disease, β-thalassemia and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases. We custom design each of our therapies to address the underlying cause of disease and have developed in-depth and effective analytical methods to understand the safety of our lentiviral vector technologies and drive the field of gene therapy forward. Founded in 2010, bluebird has the largest and deepest ex-vivo gene therapy data set in the world—setting the standard for the industry. Today, bluebird continues to forge new paths, combining our real-world experience with a deep commitment to patient communities and a people-centric culture that attracts and grows a diverse flock of dedicated birds. Community guidelines: http://bit.ly/bbbGuidelines
Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
Somerville, Massachusetts
Type
Public Company
Founded
1993
Specialties
gene therapy, gene addition, sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy
Locations
Employees at bluebird bio
Updates
- bluebird bio will be at #ASH24 this weekend discussing our experience as a gene therapy leader and presenting data demonstrating the transformational impact of bluebird’s gene therapies for #betathalassemia and #sicklecelldisease. If you are on site, find a member of the flock and say hi!
-
138,167 followers
1mo Edited
Today, bluebird bio announced it has reached an agreement with the Center for Medicare and Medicaid Innovation to offer an outcomes-based agreement for sickle cell gene therapy under the Cell and Gene Therapy (CGT) Access Model. “Ensuring timely, equitable access to gene therapy for people living with sickle cell disease insured through Medicaid has been a cornerstone of our commercial approach since approval, and we are pleased to build on this commitment by offering an outcomes-based agreement to state Medicaid agencies through the CGT Access Model. We are also pleased to be able to offer fertility preservation support to eligible patients insured by Medicaid in states that opt into the Model, as we recognize these services address an important potential barrier to access.” – Tom Klima, Chief Commercial & Operating Officer Learn more: https://lnkd.in/enaHNGqJ - The flock is excited to share that we are presenting additional long-term follow-up data from our gene therapy programs in sickle cell disease and beta-thalassemia at the upcoming 66th American Society of Hematology (ASH) Annual Meeting and Exposition. Learn more: https://lnkd.in/etdQzevw
- Congrats to Cooley's Anemia Foundation on 70 years of supporting the beta-thalassemia community. Thank you for everything you do for people living with beta-thalassemia and their families.
- Did you know that caregivers of young sickle cell warriors experience significantly greater burdens compared to the general population? Throughout #SickleCellAwarenessMonth, we're sharing stories from warriors and caregivers of sickle cell warriors that highlight aspects of #sicklecelldisease that are often overlooked. Meet Andre and Cynthia, parents to a winged warrior and founders of Discovering Moorer2life, as they share their perspective on the emotional and mental health impacts that caregivers face.
- Did you know avascular necrosis affects approximately 10% of people living with sickle cell disease, with the actual prevalence likely higher than the numbers reported. Throughout #SickleCellAwarenessMonth, we're sharing stories from warriors and caregivers of sickle cell warriors that highlight aspects of #sicklecelldisease that are often overlooked. Learn more from Kemba, a caregiver to a sickle cell warrior, about her daughter’s experience with avascular necrosis.
- Did you know that in a survey of over 2,000 people living with sickle cell disease, 65% of respondents reported experiencing fatigue in the previous month? During #SickleCellAwarenessMonth we're excited to share a series of stories from warriors focused on raising awareness of aspects of #sicklecelldisease that are often overlooked. The first feature shares the story of Andrè Marcel Harris, a sickle cell warrior who shares his daily battle with fatigue while managing sickle cell disease.
- Join us in chirping and cheering Sarah Alspach on as she represents bluebird bio on the Timmerman Traverse to the summit of Mt. Kilimanjaro. Sarah and other life sciences leaders are raising funds and awareness for Sickle Forward, a nonprofit dedicated to bringing newborn screening and basic treatment to children living with sickle cell in Africa. Direct matching funds will go towards SCD in the U.S. Learn more about her trek here: https://lnkd.in/e7ujUm4M
- September is Sickle Cell Awareness Month and the flock is flying high looking forward to raising awareness and joining warriors, caregivers, and sickle cell advocates across our communities. Stay tuned to our channels this month as we share perspectives from members of the community on aspects of #sicklecelldisease that are often overlooked and raise awareness on the ways sickle cell has impacted their lives. If you see a bird in your community at a local event, make sure you say hi!
Join now to see what you are missing
Similar pages
- Vertex Pharmaceuticals Biotechnology Research Boston, MA
- Sarepta Therapeutics Biotechnology Research Cambridge, MA
- Alnylam Pharmaceuticals Biotechnology Research Cambridge, Massachusetts
- Beam Therapeutics Biotechnology Research Cambridge, Massachusetts
- Sage Therapeutics Biotechnology Research Cambridge, MA
- Agios Pharmaceuticals Pharmaceutical Manufacturing Cambridge, MA
- CRISPR Therapeutics Biotechnology Research Boston, MA
- Verve Therapeutics Biotechnology Research Boston, Massachusetts
- Alexion Pharmaceuticals, Inc. Biotechnology Research Boston, Massachusetts
- 2seventy bio Biotechnology Cambridge, Massachusetts
Browse jobs
- bluebird bio jobs 36 open jobs
- Manager jobs 1,880,925 open jobs
- Implementation Manager jobs 138,098 open jobs
- Reimbursement Manager jobs 21,923 open jobs
- Nurse jobs 683,200 open jobs
- Account Manager jobs 121,519 open jobs
- Director jobs 1,220,357 open jobs
- Medical Science Liaison jobs 2,540 open jobs
- Associate Director jobs 125,209 open jobs
- Project Manager jobs 253,048 open jobs
- Director of Patient Services jobs 32,030 open jobs
- Accounting Manager jobs 81,749 open jobs
- Consultant jobs 760,907 open jobs
- Clinical Manager jobs 86,720 open jobs
- Clinical Research jobs 103,468 open jobs
- Senior Director jobs 117,535 open jobs
- Advocate jobs 174,946 open jobs
- Analyst jobs 694,057 open jobs
- Case Manager jobs 55,219 open jobs
- Regulatory Associate jobs 12,119 open jobs
Stock
BLUE
January 22, 2025
NASDAQ
20 minutes delay
Open
8.15
Low
7.71
High
8.362
Data from Refinitiv